Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Brouwer, V. Nijenhuis, R. Delewi, R. Hermanides, W. Holvoet, C. Dubois, P. Frambach, B. Bruyne, G. Houwelingen, J. Heyden, P. Toušek, F. Kley, I. Buysschaert, C. Schotborgh, B. Ferdinande, P. Harst, J. Roosen, J. Peper, Frederick Thielen, L. Veenstra, D. Yin, M. Swaans, B. Rensing, A. Hof, L. Timmers, J. Kelder, P. Stella, J. Baan, J. Berg (2020)
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.The New England journal of medicine
G. Ussia, M. Scarabelli, M. Mulé, M. Barbanti, K. Sarkar, V. Cammalleri, S. Immé, P. Aruta, A. Pistritto, Simona Gulino, W. Deste, D. Capodanno, C. Tamburino (2011)
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.The American journal of cardiology, 108 12
(2014)
AHA/ACC focused update of the
J. Rodés‐Cabau, J. Masson, R. Welsh, B. Blanco, M. Pelletier, J. Webb, F. Al-Qoofi, P. Généreux, Gabriel Maluenda, M. Thoenes, J. Paradis, Chekrallah Chamandi, V. Serra, E. Dumont, M. Côté (2017)
Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.JACC. Cardiovascular interventions, 10 13
Zhiwei Feng, Zhihong Wang, Zhanshuang Qiu, Tie-jun Li, Lili Zhang, Jiajia Wang, Dashi Ying (2021)
A protocol of systematic review and meta-analysis on the efficacy, safety and bioavailability of oral methotrexate compared with parenteral methotrexate at high doses for adults patients with active rheumatoid arthritis
M. Verdoia, L. Barbieri, M. Nardin, H. Suryapranata, G. Luca (2017)
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.Revista espanola de cardiologia, 71 4
Rick Nishimura, C. Otto, R. Bonow, B. Carabello, J. Erwin, L. Fleisher, H. Jneid, M. Mack, Christopher McLeod, P. O'Gara, V. Rigolin, T. Sundt, Annemarie Thompson (2017)
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation, 135 25
W Zuo (2019)
959J Thorac Dis, 11
Monica Verdoia, L. Barbieri, M. Nardin, Harry Suryapranata, Giuseppe Luca (2017)
Antiagregación doble frente a simple, con o sin anticoagulación, tras reemplazo percutáneo de válvula aórtica: comparación indirecta y metanálisisRevista Espanola De Cardiologia, 71
Rick Nishimura, C. Otto, R. Bonow, B. Carabello, J. Erwin, L. Fleisher, H. Jneid, M. Mack, Christopher McLeod, P. O'Gara, V. Rigolin, T. Sundt, Annemarie Thompson (2017)
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Journal of the American College of Cardiology, 70 2
S. Gandhi, J. Schwalm, J. Velianou, M. Natarajan, M. Farkouh (2015)
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.The Canadian journal of cardiology, 31 6
American Journal of Cardiovascular Drugs (2021) 21:373–376 https://doi.org/10.1007/s40256-021-00466-w RESEARCH LE T TER Meta‑Analysis Comparing the Safety and Efficacy of Dual Versus Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 1 1 2 3 Izza Shahid · Muhammad Abdullah Nizam · Muhammad Shariq Usman · Muhammad Shahzeb Khan · 4 5 Marat Fudim · Erin D. Michos Accepted: 28 January 2021 / Published online: 26 February 2021 © The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2021 Dear Editor, “TAVR,” “dual antiplatelet therapy,” “single antiplatelet therapy,” “aspirin,” “clopidogrel,” “antiplatelet,” “antithrom- Current expert consensus guidelines recommend dual anti- botic,” and “P2Y receptor antagonist.” Studies were included platelet therapy (DAPT) with aspirin and clopidogrel for if they (1) were RCTs, (2) included patients undergoing 3–6 months after transcatheter aortic valve implantation TAVI, and (3) evaluated direct comparison between DAPT (TAVI) [1]. This recommendation, however, is based primar- (aspirin and clopidogrel) and SAPT (only aspirin) after ily on data from small observational studies, which suggest TAVI. Outcomes of interest included (1) all-cause mor- improved mortality with DAPT [2]. The recent Antiplate- tality, (2) disabling stroke, (3) myocardial infarction, (4) let Therapy for Patients Undergoing Transcatheter Aortic major bleeding, and (5) life-threatening bleeding. The two Valve Implantation (POPular-TAVI) trial highlighted that
American Journal of Cardiovascular Drugs – Springer Journals
Published: Feb 26, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.